1540‐nm fractional erbium: Glass laser is a safe and effective modality for nonablative facial rejuvenation

Background Laser treatments for facial rejuvenation are common, with ablative modalities being of more common use for this indication. Efficient nonablative modalities are of rising demand. Aim Our aim was to determine the safety and efficacy of high‐fluence, nonablative 1540‐nm fractional Erbium:glass laser for facial rejuvenation. Patients and Methods A retrospective study of patients treated with 3‐4 treatments using the 1540‐nm fractional Erbium:glass laser for facial rejuvenation, using 2500‐3000 mJ/stacked pulses (51‐61 mJ per pixel). Patients were followed‐up for 3 months following their last treatment. Before and after photos were independently blindly evaluated by 2 dermatologists, who graded them using a scale from 0 (exacerbation) to 4 (76%‐100% improvement) for 2 different facial regions (frontal face region and lateral canthal region). Pain perception and adverse effects as well as patient satisfaction were documented throughout the study. Results Sixteen patients completed both treatment and follow‐up period. At the 3‐months posttreatment follow‐up visit, moderate‐to‐significant improvement in rhytids appearance (mean grade of improvement: 2.93 for frontal face and 3 for lateral canthal region) was observed. Patients’ satisfaction was high (4.25). Patients reported mild and transient erythema posttreatment with no other adverse effects. Conclusion The high‐fluence 1540‐nm fractional Erbium:glass laser is a safe and effective nonablative modality for facial rejuvenation.